Schering Plough 00006302500 - Zinplava… | USA MedPremium
Zinplava Bezlotoxumab 25 mg/mL Injection for C-diff Prevention - 40 mL Vial
USAMP#17725320SKU: 00006302500Zinplava™
License Required
Product Spotlight
Zinplava™ (Bezlotoxumab) is a prescription monoclonal antibody injection designed to reduce the recurrence of Clostridium difficile (C-diff) infection in adults 18 years and older who are at high risk and are currently being treated with antibiotics for C-diff.
Unlike traditional antibacterial medications, Zinplava targets C-diff toxins, preventing them from damaging the intestines and does not directly kill bacteria.
Each single-dose vial contains 25 mg/mL of Bezlotoxumab for intravenous administration, ensuring precise and targeted therapy.
